PRUDENTIAL PLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 898419 LONDON, X0

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,768,018

-$11,071 QoQ

Shares Held

35,365

-17.8% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#207

of 664 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRUDENTIAL PLC holds $29,580,493 across 10 Biotechnology names. HALO ranks #4 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	19,710	$9,790,548
2	RVMD	Revolution Medicines, Inc.	24,557	$4,599,034
3	REGN	Regeneron Pharmaceuticals, Inc.	5,829	$3,634,614
4	HALO	Halozyme Therapeutics, Inc. This page	35,365	$2,768,018
5	INSM	INSMED Inc	24,458	$2,607,711
6	ALNY	Alnylam Pharmaceuticals, Inc.	7,696	$2,316,726
7	EXEL	Exelixis, Inc.	37,249	$2,026,717
8	INCY	Incyte Corp	7,710	$874,005

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,768,018	35,365	-17.8%	Shares	Defined	2026-08-14
2026-03-31	$2,779,089	43,000	-38.8%	Shares	Defined	2026-05-14
2025-12-31	$4,727,824	70,250	+79.3%	Shares	Defined	2026-02-11
2025-09-30	$2,872,947	39,173	-8.5%	Shares	Defined	2025-11-14
2025-06-30	$2,227,392	42,818	-39.0%	Shares	Defined	2025-08-12
2025-03-31	$4,482,588	70,249	+21.0%	Shares	Defined	2025-05-13
2024-12-31	$2,776,565	58,075	+3.2%	Shares	Defined	2025-02-13
2024-09-30	$3,220,436	56,262	+34.2%	Shares	Defined	2024-11-13
2024-06-30	$2,194,826	41,918	0.0%	Shares	Defined	2024-08-07
2024-03-31	$1,705,224	41,918	+24.1%	Shares	Defined	2024-05-14
2023-12-31	$1,248,250	33,773	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.